SQUAWK/NEWS
Menu
Live News EQUITY L impact

AstraZeneca - Enters Exclusive Global License Agreement For Zegfrovy With Dizal Pharmaceutical

AstraZeneca - Enters Exclusive Global License Agreement For Zegfrovy With Dizal Pharmaceutical

AstraZeneca - Enters Exclusive Global License Agreement For Zegfrovy With Dizal Pharmaceutical